Quentin Wright

5PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 31, 2024
Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity.

Quentin G Wright, Debottam Sinha, James W Wells

|Feb 25, 2023
Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer.

Farrhana Z Firdaus, Stacey Bartlett, Waleed M Hussein

|Dec 23, 2022
Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade.

Debottam Sinha, Philip Moseley, Xuehan Lu

|Jul 20, 2021
PD-1 and beyond to Activate T Cells in Cutaneous Squamous Cell Cancers: The Case for 4-1BB and VISTA Antibodies in Combination Therapy.

Quentin Wright, Jazmina L Gonzalez Cruz, James W Wells

|Jun 02, 2021
Evolution of Cancer Vaccines-Challenges, Achievements, and Future Directions.

Ban Qi Tay, Quentin Wright, Rahul Ladwa

Pageof 1

Frequent Collaborators

4 joint publications

James W Wells

4 joint publications

Jazmina L Gonzalez Cruz

3 joint publications

Graham Robert Leggatt

1 joint publications

Debottam Sinha